scholarly journals The pilot, proof of concept REMOTE-COVID trial: remote monitoring use in suspected cases of COVID-19 (SARS-CoV 2)

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Fahad Mujtaba Iqbal ◽  
Meera Joshi ◽  
Gary Davies ◽  
Sadia Khan ◽  
Hutan Ashrafian ◽  
...  

Abstract Background SARS-CoV-2 has ever-increasing attributed deaths. Vital sign trends are routinely used to monitor patients with changes in these parameters preceding an adverse event. Wearable sensors can measure vital signs continuously and remotely, outside of hospital facilities, recognising early clinical deterioration. We aim to determine the feasibility & acceptability of remote monitoring systems for quarantined individuals in a hotel suspected of COVID-19. Methods A pilot, proof-of-concept, feasibility trial was conducted in engineered hotels near London airports (May–June 2020). Individuals arriving to London with mild suspected COVID-19 symptoms requiring quarantine, as recommended by Public Health England, or healthcare professionals with COVID-19 symptoms unable to isolate at home were eligible. The SensiumVitals™ patch, measuring temperature, heart & respiratory rates, was applied on arrival for the duration of their stay. Alerts were generated when pre-established thresholds were breeched; trained nursing staff could consequently intervene. Results Fourteen individuals (M = 7, F = 7) were recruited; the mean age was 34.9 (SD 11) years. Mean length of stay was 3 (SD 1.8) days. In total, 10 vital alerts were generated across 4 participants, resulting in telephone contact, reassurance, or adjustment of the sensor. No individuals required hospitalisation or virtual general practitioner review. Discussion This proof-of-concept trial demonstrated the feasibility of a rapidly implemented model of healthcare delivery through remote monitoring during a pandemic at a hotel, acting as an extension to a healthcare trust. Benefits included reduced viral exposure to healthcare staff, with recognition of clinical deterioration through ambulatory, continuous, remote monitoring using a discrete wearable sensor. Conclusion Remote monitoring systems can be applied to hotels to deliver healthcare safely in individuals suspected of COVID-19. Further work is required to evaluate this model on a larger scale. Trial registration Clinical trials registration information: ClinicalTrials.gov Identifier: NCT04337489 (07/04/2020).

2020 ◽  
Author(s):  
Fahad Mujtaba Iqbal ◽  
Meera Joshi ◽  
Gary Davies ◽  
Sadia Khan ◽  
Hutan Ashrafian ◽  
...  

Abstract BackgroundThe outbreak of SARS-CoV-2 (coronavirus, COVID-19), declared a pandemic by the World Health Organisation (WHO) is global health problem with ever-increasing attributed deaths. Vital sign trends are routinely used to monitor patients with changes in these parameters often preceding an adverse event. Wearable sensors can measure vital signs continuously (e.g. heart rate, respiratory rate, temperature) remotely and can be utilised to recognise early clinical deterioration. MethodsWe describe the protocol for a pilot, proof-of-concept, observational study to be conducted in an engineered hotel near London airports, United Kingdom. The study is set to continue for the duration of the pandemic. Individuals arriving to London with mild symptoms suggestive of COVID-19 or returning from high risk areas requiring quarantine, as recommended by Public Health England, or healthcare professionals with symptoms suggestive of COVID-19 unable to isolate at home will be eligible for a wearable patch to be applied for the duration of their stay. Notifications will be generated should deterioration be detected through the sensor and displayed on a central monitoring hub viewed by nursing staff, allowing for trend deterioration to be noted. The primary objective is to determine the feasibility of remote monitoring systems in detecting clinical deterioration for quarantined individuals in a hotel. DiscussionThis trial should prove the feasibility of a rapidly implemented model of healthcare delivery through remote monitoring during a global pandemic at a hotel, acting as an extension to a healthcare trust. Potential benefits would include reducing infection risk of COVID-19 to healthcare staff, with earlier recognition of clinical deterioration through ambulatory, continuous, remote monitoring using a discrete wearable sensor. We hope our results can power future, robust future randomised trials.Trial registrationClinicalTrials.gov Identifier: NCT04337489


2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Fahad Mujtaba Iqbal ◽  
Meera Joshi ◽  
Gary Davies ◽  
Sadia Khan ◽  
Hutan Ashrafian ◽  
...  

Abstract Background The outbreak of SARS-CoV-2 (coronavirus, COVID-19), declared a pandemic by the World Health Organization (WHO), is a global health problem with ever-increasing attributed deaths. Vital sign trends are routinely used to monitor patients with changes in these parameters often preceding an adverse event. Wearable sensors can measure vital signs continuously (e.g. heart rate, respiratory rate, temperature) remotely and can be utilised to recognise early clinical deterioration. Methods We describe the protocol for a pilot, proof-of-concept, observational study to be conducted in an engineered hotel near London airports, UK. The study is set to continue for the duration of the pandemic. Individuals arriving to London with mild symptoms suggestive of COVID-19 or returning from high-risk areas requiring quarantine, as recommended by the Public Health England, or healthcare professionals with symptoms suggestive of COVID-19 unable to isolate at home will be eligible for a wearable patch to be applied for the duration of their stay. Notifications will be generated should deterioration be detected through the sensor and displayed on a central monitoring hub viewed by nursing staff, allowing for trend deterioration to be noted. The primary objective is to determine the feasibility of remote monitoring systems in detecting clinical deterioration for quarantined individuals in a hotel. Discussion This trial should prove the feasibility of a rapidly implemented model of healthcare delivery through remote monitoring during a global pandemic at a hotel, acting as an extension to a healthcare trust. Potential benefits would include reducing infection risk of COVID-19 to healthcare staff, with earlier recognition of clinical deterioration through ambulatory, continuous, remote monitoring using a discrete wearable sensor. We hope our results can power future, robust randomised trials. Trial registration ClinicalTrials.gov Identifier: NCT04337489.


1998 ◽  
Author(s):  
JOhn W. Lemons ◽  
Michael C. Vorwerk ◽  
Joe H. Carroll ◽  
William E. Jabour

Author(s):  
Shozo Hatanaka ◽  
Masahiko Tange ◽  
Morio Sumiyama

It is necessary to avoid spreading damage to the pipe when it is struck by construction equipment. It is difficult to install indirect methods (e.g. fiber optic sensors) for detection of construction equipment in heavy traffic areas. Therefore, remote monitoring systems, which can detect contact between such equipment and the steel of polyethylene-lined pipe, were developed and installed on a gas transmission pipeline (φ 600 mm, Length 9.4 km). Detection uses the change in pipe-to-earth resistance which is derived from inner pipe current and pipe to soil potential when contact occurs. Old and new data of pipe-to-earth resistance are continuously compared. If equipment contacts the steel pipe, pipe-to-earth resistance will drop below 100 Ω. The detection systems include maximal length sequence signal (pseudo-random signal) processing. This signal processing is superior for noise reduction. These systems also have remote monitoring of the cathodic protection condition (pipe to soil potential, current of coupons (probes), and transformer rectifier output voltage and current). From the office, pipeline lining and cathodic protection conditions are monitored at all times.


2018 ◽  
Author(s):  
Hamza Djelouat ◽  
MOHAMED Al Disi ◽  
Abbes Amira ◽  
Faycal Bensaali

Sign in / Sign up

Export Citation Format

Share Document